冠状病毒刺突糖蛋白抗体
英文名称 SARS spike glycoprotein
中文名称 冠状病毒刺突糖蛋白抗体
别 名 E2; E2 glycoprotein; Human coronavirus spike glycoprotein; Peplomer protein; S; S glycoprotein; SPIKE_CVHSA; Severe acute respiratory syndrome spike glycoprotein; Severe acute respiratory syndrome virus spike glycoprotein; Spike glycoprotein; VGL2.
说 明 书 0.2ml
研究领域 细胞生物 细菌及病毒
抗体来源 Rabbit
克隆类型 Polyclonal
交叉反应 SARS virus
产品应用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 (石蜡切片需做抗原修复)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 138kDa
性 状 Lyophilized or Liquid
浓 度 1mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from human SARS spike glycoprotein
亚 型 IgG
纯化方法 affinity purified by Protein A
储 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
PubMed PubMed
产品介绍 background:
A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive stranded RNA approximay 27 to 31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.
Function:
S1 attaches the virion to the cell membrane by interacting with human ACE2 and CLEC4M/DC-SIGNR, initiating the infection. Binding to the receptor and internalization of the virus into the endosomes of the host cell probably induces conformational changes in the S glycoprotein. Proteolysis by cathepsin CTSL may unmask the fusion peptide of S2 and activate membranes fusion within endosomes.
S2 is a class I viral fusion protein. Under the current model, the protein has at least three conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and target cell membrane fusion, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes.xy-5750R FES原癌基因酪氨酸蛋白激酶FES抗体
xy-5769R FGF16成纤维细胞生长因子16抗体
xy-5758R FAPA成纤维细胞激活蛋白α抗体
xy-5760R FAP1Fas相关磷酸酶1抗体
xy-13195R Folate Receptor 4叶酸受体4抗体
xy-2930R Frizzled 5Wnt信号受体蛋白抗体
xy-5323R phospho-CD95 (Tyr291)磷酸化载脂蛋白A1抗体
xy-5324R phospho-CD95 (Tyr232) 磷酸化载脂蛋白A1抗体
xy-5325R Phospho-FGFR1 (Tyr307)磷酸化碱性成纤维细胞生长因子受体1抗体
xy-5104R FAAH1脂肪酸酰胺水解酶1抗体
xy-13212R FRAS1细胞外基质蛋白FRAS1抗体
xy-3938R Fumarate hydratase富马酸水合酶抗体
xy-2318R FGF21成纤维细胞生长因子21抗体
xy-3998R Fibrillarin核仁纤维蛋白抗体
xy-6403R Ferritin Light Chain铁蛋白轻链抗体
xy-2358R FOXA2肝细胞核因子3抗体
xy-3980R FBP1果糖1,6-二磷酸酯酶抗体
xy-3982R Fructose 6 Phosphate Kinase6磷酸果糖激酶抗体
xy-3981R FBP2肌肉果糖二磷酸酶抗体
xy-6895R Fibrinogen gamma chain纤维蛋白原γ链抗体
xy-6896R Fibrinopeptide B纤维蛋白肽B抗体(血纤肽B)
xy-13157R FGR原癌基因c FGR抗体
xy-13158R FHOD1肢体畸形相关蛋白FHOD1抗体
xy-13159R phospho-FHOD1 (Thr1141)磷酸化肢体畸形相关蛋白FHOD1抗体
xy-13160R Fibulin 2纤连蛋白2抗体
xy-13161R Fibulin 7纤连蛋白7抗体
xy-13162R Ficolin 2弹性蛋白结合蛋白Fcn2抗体
xy-13137R FAN1范可尼综合征相关蛋白FAN1抗体
xy-13138R FANCA范可尼贫血组蛋白A抗体
xy-13239R FZD3卷曲蛋白3抗体